Searched for
API HOLDINGS IPO
OpenAI IPO filing could come before SpaceX goes public: Will Sam Altman beat Elon Musk and Anthropic in the biggest AI and space market race of 2026? Complete details on Wall Street’s largest IPO wave- Symbiotec Pharmalab plans IPO to boost specialty pharma market
- Concord Biotech IPO: Issue subscribed 25 times on last day; check GMP and other details
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...04 Aug, 2023, 10.07 AM IST
- Concord Biotech IPO: GMP indicates strong investors' interest ahead of issue openingAhead of the issue opening, the company's shares commanded a premium of Rs Rs 325 in the unlisted market03 Aug, 2023, 06.47 PM IST
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...01 Aug, 2023, 05.25 PM IST
- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...14 Sep, 2022, 09.28 AM IST
- PharmEasy pulls out market listing planThe company will consider raising funds via rights issue, reported CNBC. API Holdings rights issue will have Compulsory Convertible Prefere...20 Aug, 2022, 07.19 PM IST
- PharmEasy not in pink of health, shares drop 50% in unlisted marketThe Mumbai-based med-tech player received the green signal from capital market's watchdog Sebi to float its Rs 6,250 crore-primary stake sa...22 Feb, 2022, 12.56 PM IST
- Sebi clears PharmEasy’s Rs 6,250 crore IPOMumbai-based API Holdings had filed its draft IPO papers in November to raise Rs 6,250 crore through a sale of primary shares. Existing sha...22 Feb, 2022, 09.13 AM IST
- PharmEasy parent company gets Sebi nod for Rs 6,250-cr public offerAPI Holdings, the parent firm of PharmEasy, has got clearance from markets regulator Securities and Exchange Board of India for the online ...22 Feb, 2022, 06.14 AM IST
- PharmEasy parent API Holdings gets Sebi nod for Rs 6,250 cr-IPOThe company will use Rs 1,929 crore from the IPO proceeds to repay or prepay borrowings and Rs 1,259 crore to fund organic growth initiativ...21 Feb, 2022, 07.02 PM IST
- IPO-bound players see up to 65% value drop in unlisted marketThe recent correction in the broader markets and dull listing pops due to ultra higher valuations is weighing on the sentiments in the list...11 Jan, 2022, 12.50 PM IST
- MedPlus shows pharma retail has lots more in storeAmidst the Covid pandemic, MedPlus Health Service became the first standalone pharmacy retail chain to get listed on the Indian bourses. Th...25 Dec, 2021, 01.15 PM IST
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...11 Nov, 2021, 10.40 AM IST
- PharmEasy parent API Holdings files draft papers for Rs 6,250 crore IPOAPI Holdings intends to utilise the net proceeds for prepayment or repayment of all or a portion of certain outstanding borrowings availed ...10 Nov, 2021, 08.56 AM IST
- PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...30 Oct, 2021, 09.45 PM IST
- PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...14 Sep, 2021, 08.22 PM IST
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.14 Sep, 2021, 06.00 AM IST
- TPG-backed PharmEasy owner mulls $1 billion IPOThe company, backed by TPG and Temasek Holdings Pte, is working with advisers on a potential offering that could take place by March 202210 Aug, 2021, 05.36 PM IST
Load More
